FDA Serves Up More Warnings: Avon Cited For Touting Druglike Benefits

Claims cited in FDA’s warning to Avon Products Inc. include statements suggesting collagen-building and wrinkle-plumping benefits, as well as comparisons to in-clinic injections and the assertion that technology in the firm’s Anew Reversalist products can help “reactivate skin’s repair process to recreate fresh skin.” Avon has 15 days to reply.

[Avon Products Inc.]becomes one of six cosmetics companies to be hit over the course of a month by FDA warning letters. Like the others, Avon’s letter asserts that products on its website, as marketed, exceed the definition of a cosmetic under the Federal Food, Drug and Cosmetic Act.

“The claims on your website indicate that these products are intended to affect the structure or any function of the human body, rendering them

More from United States

More from North America